Dyspepsia
198
17
18
123
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
16 trials with published results (8%)
Research Maturity
123 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.1%
10 terminated out of 198 trials
92.5%
+6.0% vs benchmark
33%
66 trials in Phase 3/4
13%
16 of 123 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 123 completed trials
Clinical Trials (198)
Famotidine and Antacids for Treatment of Dyspepsia
Effect of Digestive Enzymes as Add on Therapy on Patients With Functional Dyspepsia.
Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection
Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia
Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)
Domperidone in Treating Patients With Gastrointestinal Disorders
Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound
Functional Digestive Disorders Observatory
Effect of Gastrogenic Microbiota in FD
Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms
The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Treatment of Functional Abdominal Distension by Non-instrumental Biofeedback
Visible Abdominal Distension
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
A Study of Chios Mastic Water in Dyspepsia
High Resolution Gastric Mapping and Gastroduodenal Manometry